Osman Khan to Cross-Over Studies
This is a "connection" page, showing publications Osman Khan has written about Cross-Over Studies.
Connection Strength
0.049
-
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia. 2022 Jul; 28(4):548-556.
Score: 0.049